163 related articles for article (PubMed ID: 36135645)
21. Value of β-D-glucan and Candida albicans germ tube antibody for discriminating between Candida colonization and invasive candidiasis in patients with severe abdominal conditions.
León C; Ruiz-Santana S; Saavedra P; Castro C; Ubeda A; Loza A; Martín-Mazuelos E; Blanco A; Jerez V; Ballús J; Alvarez-Rocha L; Utande-Vázquez A; Fariñas O
Intensive Care Med; 2012 Aug; 38(8):1315-25. PubMed ID: 22752333
[TBL] [Abstract][Full Text] [Related]
22. Use of 1,3-Beta-D-Glucan concentration in peritoneal fluid for the diagnosis of intra-abdominal Candidiasis in Critically-ill patients.
Nourry É; Wallet F; Darien M; Menotti J; Dupont D; Allaouchiche B; Argaud L; Richard JC; Guichon C; Rimmelé T; Bohe J; Thiollère F; Vassal O; Lepape A; Wallon M; Persat F; Friggeri A
Med Mycol; 2023 Mar; ():. PubMed ID: 36941133
[TBL] [Abstract][Full Text] [Related]
23. Performance evaluation of the (1,3)-β-D-glucan detection assay in non-intensive care unit adult patients.
Murri R; Camici M; Posteraro B; Giovannenze F; Taccari F; Ventura G; Scoppettuolo G; Sanguinetti M; Cauda R; Fantoni M
Infect Drug Resist; 2019; 12():19-24. PubMed ID: 30588044
[TBL] [Abstract][Full Text] [Related]
24. Measuring (1,3)-β-D-glucan in tracheal aspirate, bronchoalveolar lavage fluid, and serum for detection of suspected Candida pneumonia in immunocompromised and critically ill patients: a prospective observational study.
Su KC; Chou KT; Hsiao YH; Tseng CM; Su VY; Lee YC; Perng DW; Kou YR
BMC Infect Dis; 2017 Apr; 17(1):252. PubMed ID: 28390391
[TBL] [Abstract][Full Text] [Related]
25. C. auris and non-C. auris candidemia in hospitalized adult and pediatric COVID-19 patients; single center data from Pakistan.
Moin S; Farooqi J; Rattani S; Nasir N; Zaka S; Jabeen K
Med Mycol; 2021 Dec; 59(12):1238-1242. PubMed ID: 34625790
[TBL] [Abstract][Full Text] [Related]
26. Contribution of Candida biomarkers and DNA detection for the diagnosis of invasive candidiasis in ICU patients with severe abdominal conditions.
León C; Ruiz-Santana S; Saavedra P; Castro C; Loza A; Zakariya I; Úbeda A; Parra M; Macías D; Tomás JI; Rezusta A; Rodríguez A; Gómez F; Martín-Mazuelos E;
Crit Care; 2016 May; 20(1):149. PubMed ID: 27181045
[TBL] [Abstract][Full Text] [Related]
27. Comparative Analysis of the Wako β-Glucan Test and the Fungitell Assay for Diagnosis of Candidemia and Pneumocystis jirovecii Pneumonia.
Friedrich R; Rappold E; Bogdan C; Held J
J Clin Microbiol; 2018 Sep; 56(9):. PubMed ID: 29899003
[TBL] [Abstract][Full Text] [Related]
28. Automation of serum (1→3)-beta-D-glucan testing allows reliable and rapid discrimination of patients with and without candidemia.
Prüller F; Wagner J; Raggam RB; Hoenigl M; Kessler HH; Truschnig-Wilders M; Krause R
Med Mycol; 2014 Jul; 52(5):455-61. PubMed ID: 24906361
[TBL] [Abstract][Full Text] [Related]
29. Epidemiology of Candidemia and Fluconazole Resistance in an ICU before and during the COVID-19 Pandemic Era.
Routsi C; Meletiadis J; Charitidou E; Gkoufa A; Kokkoris S; Karageorgiou S; Giannopoulos C; Koulenti D; Andrikogiannopoulos P; Perivolioti E; Argyropoulou A; Vasileiadis I; Vrioni G; Paramythiotou E
Antibiotics (Basel); 2022 Jun; 11(6):. PubMed ID: 35740177
[TBL] [Abstract][Full Text] [Related]
30. Increase in Candida parapsilosis fungemia in critical care units: a 6-years study.
Horasan ES; Ersöz G; Göksu M; Otag F; Kurt AO; Karaçorlu S; Kaya A
Mycopathologia; 2010 Oct; 170(4):263-8. PubMed ID: 20524154
[TBL] [Abstract][Full Text] [Related]
31. Clinical Relevance and Prognostic Value of Persistently Negative (1,3)-β-D-Glucan in Adults With Candidemia: A 5-year Experience in a Tertiary Hospital.
Agnelli C; Bouza E; Del Carmen Martínez-Jiménez M; Navarro R; Valerio M; Machado M; Guinea J; Sánchez-Carrillo C; Alonso R; Muñoz P
Clin Infect Dis; 2020 Apr; 70(9):1925-1932. PubMed ID: 31680136
[TBL] [Abstract][Full Text] [Related]
32. The added value of (1,3)-β-D-glucan for the diagnosis of Invasive Candidiasis in ICU patients: a prospective cohort study.
Christner M; Abdennadher B; Wichmann D; Kluge S; Pepić A; Aepfelbacher M; Rohde H; Olearo F
Infection; 2024 Feb; 52(1):73-81. PubMed ID: 37322388
[TBL] [Abstract][Full Text] [Related]
33. Clinical characteristics and predictors of mortality in patients with candidemia: a six-year retrospective study.
Jia X; Li C; Cao J; Wu X; Zhang L
Eur J Clin Microbiol Infect Dis; 2018 Sep; 37(9):1717-1724. PubMed ID: 30030692
[TBL] [Abstract][Full Text] [Related]
34. Candida auris Candidemia in Critically Ill, Colonized Patients: Cumulative Incidence and Risk Factors.
Briano F; Magnasco L; Sepulcri C; Dettori S; Dentone C; Mikulska M; Ball L; Vena A; Robba C; Patroniti N; Brunetti I; Gratarola A; D'Angelo R; Di Pilato V; Coppo E; Marchese A; Pelosi P; Giacobbe DR; Bassetti M
Infect Dis Ther; 2022 Jun; 11(3):1149-1160. PubMed ID: 35404010
[TBL] [Abstract][Full Text] [Related]
35. Risk factors of invasive candidiasis in critical cancer patients after various gastrointestinal surgeries: A 4-year retrospective study.
Xia R; Wang D
Medicine (Baltimore); 2019 Nov; 98(44):e17704. PubMed ID: 31689800
[TBL] [Abstract][Full Text] [Related]
36. Diagnostic performance of 1→3-β-d-glucan in neonatal and pediatric patients with Candidemia.
Montagna MT; Coretti C; Lovero G; De Giglio O; Montagna O; Laforgia N; Santoro N; Caggiano G
Int J Mol Sci; 2011; 12(9):5871-7. PubMed ID: 22016633
[TBL] [Abstract][Full Text] [Related]
37. Usefulness of ß-D-glucan for diagnosis and follow-up of invasive candidiasis in onco-haematological patients.
Guitard J; Isnard F; Tabone MD; Antignac M; Brissot E; Senghor Y; Petit A; Leverger G; Hennequin C
J Infect; 2018 May; 76(5):483-488. PubMed ID: 29432826
[TBL] [Abstract][Full Text] [Related]
38. The diagnostic value of (1,3)-β-D-glucan alone or combined with traditional inflammatory markers in neonatal invasive candidiasis.
Guo J; Wu Y; Lai W; Lu W; Mu X
BMC Infect Dis; 2019 Aug; 19(1):716. PubMed ID: 31412796
[TBL] [Abstract][Full Text] [Related]
39. (1,3)-β-D-glucan is able to predict therapeutic failure of patients with candidemia and not only mortality.
Esteves P; Lopes Lima S; Salles de Azevedo Melo A; Maria Beirão E; Nucci M; Colombo AL
Mycoses; 2021 Mar; 64(3):264-271. PubMed ID: 33274533
[TBL] [Abstract][Full Text] [Related]
40. The Impact of COVID-19 on the Epidemiology and Outcomes of Candidemia: A Retrospective Study from a Tertiary Care Center in Lebanon.
El Zakhem A; Mahmoud O; Zakhour J; Nahhal SB; El Ghawi N; Omran N; El Sheikh WG; Tamim H; Kanj SS
J Fungi (Basel); 2023 Jul; 9(7):. PubMed ID: 37504757
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
